Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience.
Diamanti L, Picca A, Bini P, Gastaldi M, Alfonsi E, Pichiecchio A, Rota E, Rudà R, Bruno F, Villani V, Galiè E, Vogrig A, Valente M, Zoccarato M, Poretto V, Giometto B, Cimminiello C, Del Vecchio M, Marchioni E.
Diamanti L, et al. Among authors: bruno f.
Neurol Sci. 2022 Mar;43(3):2031-2041. doi: 10.1007/s10072-021-05561-z. Epub 2021 Aug 23.
Neurol Sci. 2022.
PMID: 34424427
Free article.